Human dignity: A guide to policy making in the biotechnology era?

This source preferred by Roger Brownsword

This data was imported from PubMed:

Authors: Caulfield, T. and Brownsword, R.

Journal: Nat Rev Genet

Volume: 7

Issue: 1

Pages: 72-76

ISSN: 1471-0056

DOI: 10.1038/nrg1744

This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.

This data was imported from Scopus:

Authors: Caulfield, T. and Brownsword, R.

Journal: Nature Reviews Genetics

Volume: 7

Issue: 1

Pages: 72-76

eISSN: 1471-0064

ISSN: 1471-0056

DOI: 10.1038/nrg1744

This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies. © 2005 Nature Publishing Group.

This data was imported from Europe PubMed Central:

Authors: Caulfield, T. and Brownsword, R.

Journal: Nature reviews. Genetics

Volume: 7

Issue: 1

Pages: 72-76

eISSN: 1471-0064

ISSN: 1471-0056

This article explores the ways in which human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning. Increasingly, human dignity is used as a form of general condemnation and as blanket justification for regulatory restraint. However, this use of human dignity marks a significant departure from the traditional, human-rights informed view of human dignity that has dominated bioethics debates for decades. In addition, on its own, it stands as dubious justification for policies that are aimed at constraining controversial biotechnologies.

The data on this page was last updated at 05:09 on February 27, 2020.